Safety and Efficacy of OPN Balloon in Patients With Calcified Coronary Artery Disease

被引:5
|
作者
Senguttuvan, Nagendra Boopathy [1 ,4 ]
Singh, Harsimran [1 ]
Kumar, Balakrishnan Vinod [1 ]
Kongara, Rahul Chowdary [1 ]
Abdulkader, Rizwan Suliankatchi [2 ]
Anandaram, Asuwin [3 ]
Krishnamurthy, Preetam [1 ]
Balasubramaniyan, Jayanthy Venkata [1 ]
Sadhanandham, Shanmugasundram [1 ]
Ramesh, Sankaran [1 ]
Manokar, Panchanatham [1 ]
Muralidharan, Thoddi Ramamurthy [1 ]
Murthy, Jayanthy S. N. [1 ]
Thanikachalam, Sadagopan [1 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res SRIHER, Dept Cardiol, 1 Ramachandra Nagar,Porur, Chennai 600116, Tamil Nadu, India
[2] Natl Inst Epidemiol, ICMR, Scientist D, Chennai, India
[3] Sri Ramachandra Inst Higher Educ & Res SRIHER, Dept Clin Res, 1,Ramachandra Nagar,Porur, Chennai 600116, Tamil Nadu, India
[4] SRIHER, Dept Cardiol, Chennai, India
关键词
OPN balloon; Calcified lesions; Stent expansion; CAD; SIROLIMUS-ELUTING STENTS; LESIONS;
D O I
10.1016/j.carrev.2023.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with symptomatic calcified coronary lesions have poor outcomes. Such lesions require additional atherectomy devices for bed preparation. Aim: To assess the safety and efficacy of OPN balloon in patients with calcified coronary lesions.Methods: This is an investigator-initiated, prospective, observational study. The primary outcome of the study was a procedural success.Results: We studied 71 patients (133 lesions). Maximum lesions were located in LAD [46.6 %]. The OPN balloon was used for pre-dilatation alone in 28.6 % (Pre-stent OPN group), post-dilatation alone in 63.2 % of lesions (Post-stent OPN group), and in both situations in 8.3 % of lesions with procedural success in 98.5 % of patients. Further dilatation with different NC balloons was required in both groups (30 %). The median (IQR) OPN balloon diameter in the pre-and post-stent OPN group were 2.5 (2.5, 3.0) and 3.0 (3.0,3.0) mm (p = 0.001), respectively. The difference between the diameter of the stent and OPN balloon used in pre-stent OPN group was 0.5 (0.2, 0.5) mm while it was 0.0 (0.0,0.2) mm in the post-stent OPN group (p < 0.001). Eight complications and two deaths occured. Distal shaft rupture was also noticed. Conclusion: OPN balloon is safe, and effective in treating calcified coronary lesions. We propose to undersize the balloon by 0.5 mm for pre-dilatation followed by 0.25 mm larger NC balloon if needed. In the post-dilatation group, use a 1:1 size balloon in a non-tortuous straight segment. Use imaging especially when (1) the pressure taken more than the rated burst pressure, (2) an OPN balloon size is >= 3 mm (3) using 1:1 size OPN balloon in a tortuous segment.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 50 条
  • [41] CALCIFIED ASCENDING AORTA AND CORONARY-ARTERY DISEASE
    OLEARCHYK, AS
    ANNALS OF THORACIC SURGERY, 1995, 59 (04): : 1013 - 1015
  • [42] Calcified Saccular Coronary Artery Aneurysm of Kawasaki Disease
    Singhal, Manphool
    Vignesh, Pandiarajan
    Khandelwal, N.
    Singh, Surjit
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 (05) : E96 - E96
  • [43] Calcified versus non-calcified plaque volume fraction in patients with coronary artery disease and their association with outcome
    Kuneman, J. H.
    Van Den Hoogen, I. J.
    Schultz, J.
    Maaniiity, T.
    El Mahdiui, M.
    Kamperidis, V.
    De Graaf, M. A.
    Broersen, A.
    Jukema, J. W.
    Bax, J. J.
    Saraste, A.
    Knuuti, J.
    EUROPEAN HEART JOURNAL, 2021, 42 : 159 - 159
  • [44] Enhanced Efficiency of Sequential Cutting Balloon Angioplasty in Calcified Coronary Artery Disease: The RODIN-CUT Technique
    Ungureanu, Claudiu
    Leibundgut, Gregor
    Cocoi, Mihai
    Gasparini, Gabriele
    Colletti, Giuseppe
    Avran, Alexandre
    Poletti, Enrico
    Moroni, Alice
    Mangieri, Antonio
    Dumitrascu, Silviu
    Mozid, Abdul
    Boukhris, Marouane
    Achim, Alexandru
    Zivelonghi, Carlo
    Bentakhou, Elias
    Agostoni, Pierfrancesco
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2025, 105 (04) : 805 - 812
  • [45] The Efficacy and Safety of Rosuvastatin in Patients With Coronary Heart Disease
    Kobalava, Zh. D.
    Stavtseva, Yu. V.
    KARDIOLOGIYA, 2015, 55 (11) : 80 - +
  • [46] Efficacy and Safety of Drug-coated Balloon Angioplasty for De Novo Coronary Artery Lesions
    Tsujimoto, Masanaga
    Kaetsu, Yasuhiro
    Kadotani, Makoto
    Nakamura, Hiroaki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (15) : S25 - S25
  • [47] Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation
    Kaida Y.
    Kambe T.
    Kishimoto S.
    Koteda Y.
    Suda K.
    Yamamoto R.
    Imai T.
    Hazama T.
    Takamiya Y.
    Shibata R.
    Nishida H.
    Okuda S.
    Fukami K.
    Renal Replacement Therapy, 3 (1)
  • [48] Influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of percutaneous coronary intervention
    Munhoz, D.
    Collet, C.
    Mizukami, T.
    Sonck, J.
    Matsuo, H.
    Ando, H.
    Sakai, K.
    Storozhenko, T.
    Berry, C.
    Perera, D.
    Christiansen, E.
    Shinke, T.
    Ko, B.
    De Bruyne, B.
    Johnson, N.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [49] Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease
    Shah, Sana
    Bellam, Naveen
    Leipsic, Jonathon
    Berman, Daniel S.
    Quyyumi, Arshed
    Hausleiter, Joerg
    Achenbach, Stephan
    Al-Mallah, Mouaz
    Budoff, Matthew J.
    Cademartiri, Fillippo
    Callister, Tracy Q.
    Chang, Hyuk-Jae
    Chow, Benjamin J. W.
    Cury, Ricardo C.
    Delago, Augustin J.
    Dunning, Allison L.
    Feuchtner, Gudrun M.
    Hadamitzky, Martin
    Karlsberg, Ronald P.
    Kaufmann, Philipp A.
    Lin, Fay Y.
    Chinnaiyan, Kavitha M.
    Maffei, Erica
    Raff, Gilbert L.
    Villines, Todd C.
    Gomez, Millie J.
    Min, James K.
    Shaw, Leslee J.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2014, 21 (03) : 453 - 466
  • [50] Prognostic significance of calcified plaque among symptomatic patients with nonobstructive coronary artery disease
    Sana Shah
    Naveen Bellam
    Jonathon Leipsic
    Daniel S. Berman
    Arshed Quyyumi
    Jörg Hausleiter
    Stephan Achenbach
    Mouaz Al-Mallah
    Matthew J. Budoff
    Fillippo Cademartiri
    Tracy Q. Callister
    Hyuk-Jae Chang
    Benjamin J. W. Chow
    Ricardo C. Cury
    Augustin J. Delago
    Allison L. Dunning
    Gudrun M. Feuchtner
    Martin Hadamitzky
    Ronald P. Karlsberg
    Philipp A. Kaufmann
    Fay Y. Lin
    Kavitha M. Chinnaiyan
    Erica Maffei
    Gilbert L. Raff
    Todd C. Villines
    Millie J. Gomez
    James K. Min
    Leslee J. Shaw
    Journal of Nuclear Cardiology, 2014, 21 : 453 - 466